PT-141

PT-141

Injectable: 10mg/mL – 2mL Vial Nasal Spray: 2mg/mL – 10mL Spray

The recent FDA regulations have impacted the availability of certain substances essential for peptide production by compounding pharmacies. Despite these changes, we are pleased to announce that specific peptides remain available through our services, contingent upon a medical consultation. We appreciate your ongoing support as we adapt to these regulatory adjustments. To discuss your options and continue benefiting from our peptide offerings, please book a consultation with us today.

Semaglutide and Tirzepatide are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). I hereby declare that I do not have a personal or family history of MTC or MEN 2.

20 mg bottle $199
Book Consultation

Description

PT-141, also known as Bremelanotide, is a peptide developed to address Hypoactive Sexual Desire Disorder (HSDD) by enhancing sexual arousal. Unlike other treatments for sexual dysfunction, PT-141 acts on the central nervous system, making it effective for both men and women in increasing libido and improving sexual satisfaction.
Mechanism of Action:
PT-141 works by activating melanocortin receptors in the brain, particularly the MC4R receptor, which influences sexual arousal pathways. This action helps increase libido and sexual response without affecting vascular systems, unlike other treatments that target blood flow.
Available in Nasal Spray or Injectable

 

Related peptides

Frequently Asked Questions

Peptides are short chains of amino acids that perform various bodily functions, such as stimulating growth, tissue regeneration, or enhancing cognitive functions.

Peptides activate specific receptors or biochemical pathways in the body, leading to the desired therapeutic effects.

Depending on the type of peptide, benefits include improved sexual function, muscle growth, reduced inflammation, enhanced cognitive functions, and more.

Results can be seen within a few weeks after starting the therapy, although this can vary based on individual patient characteristics and the specific peptide.

Possible side effects include mild irritation at the injection site, headaches, nausea, and others, depending on the specific peptide.

The recommended frequency of use depends on the specific peptide and can range from daily use to several times a week. Your doctor will provide specific recommendations.

Peptides are not recommended for individuals with certain medical conditions, pregnant or breastfeeding women. Always consult with your doctor before starting the therapy.